An analysis published before the June 15 meeting on the eligibility of children under 5 for Pfizer’s COVID-19 vaccine receives FDA approval.
The long-awaited review of the Pfizer Inc. (PFE) and BioNTech SE (BNTX) COVID-19 vaccine for possible use in children under the age of 5 was published by the U.S. Food and Drug Administration (FDA) on June 12, 2022. According to the study results, COVID-19 vaccine receives FDA approval. the vaccination seems safe and efficient in avoiding sickness in children of that age. The investigation uncovered no new safety issues. After